4//SEC Filing
LINDER JAMES 4
Accession 0001247319-04-000121
CIK 0000849778other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 4:13 PM ET
Size
17.0 KB
Accession
0001247319-04-000121
Insider Transaction Report
Form 4
CYTYC CORPCYTC
LINDER JAMES
Sr. VP, Chief Medical Officer
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-10-18−6,500→ 42,500 totalExercise: $0.83From: 1999-12-14Exp: 2005-12-14→ Common Stock (6,500 underlying) - Exercise/Conversion
Common Stock
2004-10-18$0.83/sh+2,000$1,667→ 4,663 total - Sale
Common Stock
2004-10-18$27.71/sh−2,000$55,427→ 2,663 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-10-18−2,000→ 49,000 totalExercise: $0.83From: 1999-12-14Exp: 2005-12-14→ Common Stock (2,000 underlying) - Sale
Common Stock
2004-10-18$28.14/sh−6,500$182,883→ 2,663 total - Exercise/Conversion
Common Stock
2004-10-18$0.83/sh+6,500$5,416→ 9,163 total
Footnotes (4)
- [F1]Granted pursuant to Issuer's 1989 Stock Plan and exempt from Section 16 pursuant to Rule 16b-3.
- [F2]The sale reported on this Form 4 was made pursuant to a written trading plan adopted in accordance with SEC Rule 10b5-1 on March 4, 2004.
- [F3]Price not applicable to this transaction.
- [F4]The stock option grant on December 14, 1995 involved 600,000 shares and was exercisable as to 120,000 as of 12/5/95; exercisable as to 120,000 shares on 12/5/96; exercisable as to 120,000 on 12/5/97; exercisable as to 120,000 on 12/5/98 and exercisable as to 120,000 on 12/5/99.
Issuer
CYTYC CORP
CIK 0000849778
Entity typeother
Related Parties
1- filerCIK 0001187409
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 4:13 PM ET
- Size
- 17.0 KB